T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.93% |
| 2 | Consumer Discretionary | 13.87% |
| 3 | Financials | 13.55% |
| 4 | Industrials | 11.68% |
| 5 | Technology | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MASI
1401
DELISTED
Masimo
MASI
| $5.5M | ﹤0.01% |
206,530
+7,700
| +4% | +$190K |
|
1402
Emcor
EME
$36.7B
| $5.43M | ﹤0.01% |
138,660
+116,900
| +537% | +$4.74M |
|
1403
Pitney Bowes
PBI
$2.28B
| $5.42M | ﹤0.01% |
297,981
+10,600
| +4% | +$174K |
|
|
GGS
1404
DELISTED
GLOBAL GEOPHYSICAL SERVICES, INC COM STK
GGS
| $5.41M | ﹤0.01% |
1,995,890
+218,888
| +12% | +$757K |
|
1405
AutoNation
AN
$6.9B
| $5.36M | ﹤0.01% |
102,781
+44,300
| +76% | +$2.14M |
|
1406
Exponent
EXPO
$3.22B
| $5.35M | ﹤0.01% |
298,016
-6,400
| -2% | -$107K |
|
|
BIG
1407
DELISTED
Big Lots, Inc.
BIG
| $5.35M | ﹤0.01% |
144,307
-4,900
| -3% | -$173K |
|
|
CYBE
1408
DELISTED
Cyberoptics Corp
CYBE
| $5.34M | ﹤0.01% |
858,230
| – | – |
|
|
EV
1409
DELISTED
Eaton Vance Corp.
EV
| $5.28M | ﹤0.01% |
136,066
+1,800
| +1% | +$71.6K |
|
|
SRT
1410
DELISTED
Startek Inc.
SRT
| $5.26M | ﹤0.01% |
816,630
| – | – |
|
|
CBPO
1411
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $5.16M | ﹤0.01% |
176,729
| – | – |
|
1412
Children's Place
PLCE
$53.4M
| $5.16M | ﹤0.01% |
89,150
-5,200
| -6% | -$285K |
|
|
MACK
1413
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $5.12M | ﹤0.01% |
+171,216
| New | +$5.99M |
|
1414
ICU Medical
ICUI
$4.58B
| $5.11M | ﹤0.01% |
75,200
+2,700
| +4% | +$193K |
|
|
DWRE
1415
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $5.1M | ﹤0.01% |
+110,000
| New | +$4.96M |
|
|
ETRM
1416
DELISTED
EnteroMedics Inc.
ETRM
| $5.09M | ﹤0.01% |
3,881
| – | – |
|
|
ASRT
1417
DELISTED
Assertio
ASRT
| $5.07M | ﹤0.01% |
11,298
+170
| +2% | +$69.4K |
|
|
DRC
1418
DELISTED
DRESSER-RAND GROUP INC
DRC
| $5.02M | ﹤0.01% |
80,500
-1,100
| -1% | -$68.7K |
|
1419
HF Sinclair
DINO
$16.3B
| $5.02M | ﹤0.01% |
119,152
+4,600
| +4% | +$200K |
|
|
BONA
1420
DELISTED
BONA FILM GROUP LTD SPONSORED ADS
BONA
| $5.01M | ﹤0.01% |
954,304
-81,700
| -8% | -$375K |
|
1421
ATI
ATI
$30.9B
| $4.94M | ﹤0.01% |
161,831
-1,790
| -1% | -$50.1K |
|
1422
Magnachip Semiconductor
MX
$137M
| $4.93M | ﹤0.01% |
228,900
+127,600
| +126% | +$2.57M |
|
|
AJRD
1423
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $4.9M | ﹤0.01% |
305,910
+6,200
| +2% | +$102K |
|
|
MTEM
1424
DELISTED
Molecular Templates, Inc.
MTEM
| $4.89M | ﹤0.01% |
6,370
-30
| -0.5% | -$24.6K |
|
|
USAK
1425
DELISTED
USA Truck Inc
USAK
| $4.86M | ﹤0.01% |
542,570
-129,750
| -19% | -$796K |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.